Serum Proteomic Profiling in Patients with Bladder Cancer

Anna-Maria Korakiti, Eleni Zografos, Stavros Proikakis, Alkistis‐Maria Papatheodoridi, Kleoniki Apostolidou, Constantinos G. Zografos, D. Maniatis, Christos K Stefanou, Spyridon S Marinopoulos, Constantine Dimitrakakis, Grigorios Xepapadakis, George Th. Tsangaris, Meletios A Dimopoulos, Flora Zagouri

Article2011

Management of advanced bladder cancer in patients with impaired renal function

Evangelos Bournakis, Meletios A Dimopoulos, Aristotle Bamias

Article2023

Bladder Wall Stiffness after Cystectomy in Bladder Cancer Patients: A Preliminary Study

Sara Monteiro‐Reis, João Ferreira, Ricardo A. Pires, João Lobo, João Andrade de Carvalho, Rui L Reis, Renato Natal Jorge, Cármen Jerónimo

Article2010

ERCC1 polymorphisms in patients with advanced bladder cancer treated with platinum-based chemotherapy.

A. Bamias, Nikitas Nikitas, Alexandra Karadimou, Dimitra Gika, Vasilios Karavasilis, Evangelos Briasoulis, Michael Chrisofos, Sara E. Murray, D. Pectasides, Meletios A Dimopoulos

Article2025

Abstract 4931: Pan-cancer proteomic profiling of the EPIC cohort identifies novel plasma biomarkers of cancer risk

James Yarmolinsky, Vivian Viallon, David C. Muller, Antonio Agudo, Pietro Ferrari, Giovanna Masala, Salvatore Panico, Carlotta Sacerdote, Karl Smith-Byrne, Ruth C. Travis, Rosario Turmino, P. Martijn Kolijn, Roel Vermeulen, Monique Verschure, Nicholas J. Wareham, Elio Riboli, Marc J. Gunter